Background {#Sec1}
==========

*Acinetobacter baumannii* as an opportunistic pathogen has recently been known as a nosocomial pathogen which is associated with health care infections \[[@CR1]\]. Due to the increasing antimicrobial resistance, *A. baumannii* has emerged as a life-threatening pathogen in the three past decades. The most important mechanisms of resistance to tetracyclines in *A. baumannii* isolates are efflux pumps followed by ribosomal protections and enzymatic inactivation. To date, tetracyclines were considered as a second-line therapy for *Acinetobacter* infections. However, due to the lack of any new under-development antibiotics and decreased effectiveness of the first-line antibiotics, older ones (e.g. tetracyclines) have been taken into consideration again \[[@CR2]\]. Streptomyces species were the source of tetracycline, which is considered as the first generation of tetracyclines. Semisynthetic tetracyclines, doxycycline and minocycline, as the second generation of this group have wider spectrum. Tigecycline, a glycylcycline, has recently approved by US Food and Drug Administration (FDA) antibacterial agent. This minocycline structural analogue is indicated intravenously for the treatment of complicated infections \[[@CR3]\].

Resistance to the first and second generations of tetracyclines in *A. baumannii* isolates mainly resulted from the acquired major facilitator superfamily (MFS) efflux pumps, including *tetA*, *tetB*, *tetG*, *tetH*, *tetL*, and *tet39,* resistance nodulation division family (RND) efflux pumps nominated as *adeABC*, *adeIJK*, *adeFGH*, *adeM*, *adeDE* \[[@CR4]\], and finally ribosomal protections and enzymatic inactivation \[[@CR5]\]. *tetA* is responsible for the resistance to tetracycline and doxycycline whereas *tetB* has been found in the isolates that were also resistant to minocycline \[[@CR6]\]. Notably, the main resistance mechanisms of tetracyclines are *ade* efflux systems while coexistence with *tetA* and *tetB* determinants resulted in increasing MIC values \[[@CR7]\].

Due to the lack of accuracy in disc diffusion method, determining susceptibility to doxycycline and minocycline was recommended to be carried out by Epsilometric test (E-test) or broth microdilution assays \[[@CR8]\].

Regarding the impact of *A. baumannii* in healthcare---associated infections and rapid spreading of antibiotic-resistant strains, epidemiological investigation and determination of the clonal relationships among *A. baumannii* isolates should be considered. Some molecular techniques are currently at our disposal for typing and to clonal relatedness among clinically isolates of *A. baumannii*. The most common assay is the repetitive extragenic palindromic polymerase chain reaction-based (rep-PCR) that is simple, rapid and reliable compared to PFGE. Determining international clonal lineages (ICs) in *A. baumanii* is a useful tool for showing widespread distribution of global distributed clones \[[@CR9]\]. Outbreak strains which are more resistant to antibiotics and might be associated with specific clinical syndromes, could be identified by such aforementioned studies \[[@CR10]\]. The present study aimed to compare the resistance range of tetracycline, doxycycline and minocycline in the two periods of 2011 and 2015. Moreover, resistance determinants *tetA* and *tetB* were screened in clinical isolates of *A. baumannii*. Also, to determine the clonal transition dynamics and relatedness of isolates, international clonal lineage investigation and rep-PCR assays were performed in Ghaem Hospital, Mashhad, Iran.

Methods {#Sec2}
=======

Bacterial isolates and hospital setting {#Sec3}
---------------------------------------

A total of 72 non-duplicate isolates of carbapenem resistant *A. baumannii* (CRAB) were collected from admitted patients at the Intensive Care Units (ICUs) of Ghaem Hospital (1000-bed referral university hospital, with NICU, PICU and adult's ICU wards). The ethics committee of hospital and institutional review boards approved this study, and recommendations by STROBE were considered to report the results \[[@CR11]\]. Thirty-six isolates were collected in 2011, and the other 36 isolates were obtained in 2015. In the first stage, these isolates were identified by API20NE as *Acinetobacter baumannii*-*calcoaceticus* complex, and for confirming as *A. baumannii*, all of the isolates were investigated by OXA-51-like β-lactamase and *gyrB* multiplex PCR amplification according to previous studies \[[@CR12]\]. The isolates were stored in 30% v/v glycerol/triptic soy broth medium at −70 °C.

Antibacterial susceptibility testing and efflux pump activity evaluation {#Sec4}
------------------------------------------------------------------------

In order to evaluate antimicrobial susceptibility to doxycycline, minocycline and tetracycline, broth micro dilution method was used according to CLSI M07-A9 instructions \[[@CR13]\] and the results were interpreted according to CLSI M100-S25 guidelines \[[@CR14]\]. In this study, the intermediate isolates were also considered as resistant. All antibiotic chemicals were purchased from Sigma Chemicals Co., Inc. (St. Louis, USA). *Escherichia coli* ATCC 25922 and *Pseudomonas aeruginosa* ATCC 27853 were used as reference strains.

For tetracyclines resistant isolates, MICs of the three aforementioned antibacterials were repeated in the presence of the following efflux pump inhibitors (EPIs) by broth microdilution method. Carbonyl cyanide 3-chlorophenylhydrazone (CCCP), phenyl-arginine-β-naphthylamide (PAβN), 1-(1-naphthylmethyl)-piperazine (NMP), reserpine and verapamil (Sigma), CCCP, PAβN, NMP, reserpine, and verapamil were added to the broth at the final concentrations of 5, 70, 100, 50, and 100 g/L, respectively \[[@CR4]\]. A fourfold or greater decrease in the MIC values in the presence of EPIs was considered as significant inhibition.

PCR amplification of *tetA and tetB* {#Sec5}
------------------------------------

The existence of tetracycline resistant determinants, *tetA* and *tetB,* were detected by the PCR assay according to previous studies with some modifications \[[@CR15]\]. Briefly, the template DNA for PCR reactions was obtained from heating 200 μL suspension of overnight bacterial cultures for 10 min at 95 °C and quickly refrigerating for 10 min followed by centrifugation at 15,000*g* for 5 min, and then discarding the supernatant. PCR products were analyzed by electrophoresis on agarose gels 2% using a 100plus DNA ladder Fermentase (Thermo Fisher Scientific, Germany) as a size marker.

Clonal and international lineage relatedness {#Sec6}
--------------------------------------------

To discover clonal relationships among the isolates of *A. baumannii*, we exploited two molecular typing methods. All the isolates were subjected to rep-PCR and international clonal lineage (IC) investigations.

A pair of primers with indication for REP sequences of *A. baumannii* were used as amplification primers, as described previously. The concentration of REP primers, REP1 and REP2, were 50 pmol/mL \[[@CR16]\]. PCR products were detected by electrophoresis on 2% agarose using a 100 bp plus DNA ladder (Thermo Fisher Scientific, Germany), as a size marker. GelJ software (v. 1.3) was utilized in order to analyze the band patterns, considering dice tolerance 2.0 and UPGMA method to depict dendrogram. Isolates with at least 95% similarity were considered related and defined as the same rep-PCR cluster. IC lineages detection was done by a multiplex PCR assay of all the strains to find *csuE*, OXA-66/69 and *ompA* genes \[[@CR9]\].

Statistical study {#Sec7}
-----------------

All statistical analyses were performed using SPSS v.16.0. A univariate analysis was carried out using Pearson's Chi square test for nominal variables in two independent groups. A P value of \<0.05 was considered significant.

Results {#Sec8}
=======

Antimicrobial susceptibility and molecular detection of *tetA and tetB* {#Sec9}
-----------------------------------------------------------------------

In two periods of 2011 and 2015, 72 CRAB isolates (36 isolates per year) were collected. The percentages of tetracyclines resistant isolates in 2015 were obviously higher than those in 2011. About 70% (26 of 36) of isolates in 2011 were resistant to tetracycline, while in 2015, the resistance rates were increased up to 90% (32 of 36). The increasing rates were also observed for doxycycline and minocycline. In 2011, 2.7% (1 of 36) of the isolates were resistant to doxycycline versus 84.2% (30 of 36) in 2015. None of the isolates were resistant to minocycline in 2011, but the resistance rate increased to 52.6% (19 of 36) after 4 years (Table [1](#Tab1){ref-type="table"}).Table 1Broth microdilution susceptibilities and MIC range distribution of 72 *A. baumannii* isolates (results represented by %)20112015Agent/MIC~mg/L~≤48≥16≤48≥16TET273340102.687.4DOX980215.8084.2MIN1000047.431.621*TET* tetracycline, *DOX* doxycycline, *MIN* minocycline

MIC~90~ of minocycline, doxycycline and tetracycline were dramatically increased after passing 4 years (Fig. [1](#Fig1){ref-type="fig"}). MICs~90~ for minocycline, doxycycline and tetracycline in 2011 were 2, 4 and 32 mg/L, respectively, whereas in 2015 they obviously increased to 16, 64 and 1024 mg/L, respectively. The MICs of resistant isolate for these antibacterials in the presence of EPIs were significantly changed. About 88% of tetracycline resistant isolates (51 out of 58) showed decreasing MIC when tetracycline was presented with EPIs. The effect of EPIs on the MICs of doxycycline and minocycline resistant isolates (31 and 19 out of 72, respectively), was reduced in 26% (8 of 31) and 47% (9 of 19) of doxycycline and minocycline, respectively. The tetracycline resistance determinant *tetB* was detected in all of the isolates of both years, however, tetA was not found in any of the isolates.Fig. 1MIC~90~ comparison of tetracycline, minocycline and doxycycline in 36 isolates in 2011 versus 36 isolates in 2015

Epidemiological investigations and international clonal lineages {#Sec10}
----------------------------------------------------------------

About 10 distinctive rep-PCR clusters (named A to J) and eight singleton isolates were inferred from the band patterns (Fig. [2](#Fig2){ref-type="fig"}). Clusters A--E and G consisted of representatives of strains of 2011, and clusters H, I and J indicated strains of 2015. Cluster F consisted of strains of both years of 2011 and 2015. Our data showed that up to 94% of all the strains were included in nine distinct clusters and only 6% of them had common roots.Fig. 2REP generated dendrogram of all isolates with considering more than 95% of similarity for clustering of isolates. *MN* Mashhad new, *Mo* Mashhad old, *UN* unknown

Results from Multiplex PCR revealed that 42% of strains in 2011 were IC1, 28% were IC2 and 30% were unknown, while only 22% of strains in 2015 were attributed to IC1, 36% to IC2 and 42% were unknown.

Discussion {#Sec11}
==========

This integrative study provides concerns about a formidable increase in drug resistance to *A. baumannii* concomitant with prospects to clonal transmission dynamics of outbreak isolates over a 4-year interval between 2011 and 2015.

Due to the increase in resistance to majority of antibiotics in *A. baumannii*, evaluating antimicrobial susceptibility of older agents that was not used in clinical practice is of interest to overcome the Acinetobacter infections. A previous study showed the satisfying effectiveness of tetracyclines against *A. baumannii* in vitro \[[@CR15]\]. In this regard, our data showed that the resistance rates for tetracycline, doxycycline and minocycline in 2011 were 73, 2 and 0%, respectively. Meanwhile, these resistance rates increased to 90, 84.2 and 52.6% in the case of the noted antibiotics in 2015. Because of not using tetracyclines in clinical practice of *A. baumannii* infections in our hospitalized patients, the increased resistance to these three agents was not expected. Significant increasing resistance in our hospital setting is in correlation with another previous study in Iran \[[@CR17]\]. Being consistent with our study, Maleki et al. reported that resistance rates of tetracycline, minocycline and doxycycline to *A. baumannii* isolates in Tehran in 2013 were 89, 35 and 25%, respectively.

The *tetA* and *tetB* determinants are common in tetracyclines resistant *A. baumannii* isolates \[[@CR6]\]. Our results are also in agreement with a previous study by Farsiani et al. \[[@CR18]\] in 2015 who reported that the *tetA* gene was not found in any of the strains whereas *tetB* was detected in 100% of the strains. In our study, the increased level of resistance to tetracyclines was observed in spite of any detectable differences in prevalence of *tetA* and *tetB* in all of the isolates. The effect of EPIs herein on most of the tetracycline resistant strains can explain that the increasing resistance is related to efflux pumps activity.

By using molecular typing methods, we are able to discriminates widespread clonal lineages of *A. baumannii* responsible for hospital clonal transition dynamics in outbreaks worldwide \[[@CR19]\]. Amongst ten clusters obtained from evaluating all of the strains by rep-PCR, six clusters (A--E and G) included representatives of strains of 2011. The 2015 strains were classified in three clusters (H, I and J), and one cluster (F) contained strains of both years. At a glance, it can be inferred that more than 94% of all the strains were classified in distinct clusters and less than 6% of the strains are in a common (F) cluster. Furthermore, up to 91% of the strains in 2015 were classified in three clusters. Considering the decrease in the number of clusters from 2011 to 2015, it certainly indicated that new lineages with different resistance patterns were replaced over 4 years.

In this study, the percentage rates of IC1 and IC2 in the strains of 2011 were 42 and 28%, whereas in the strains of 2015 they were 22 and 36%, respectively. Higher prevalence of IC2 strains in 2015 compared with 2011, is consistent with the previous reports which state that in the recent years IC2 was a more common lineage in antibiotic-rich environments of hospitals \[[@CR20]\]. A pervious study by Turton et al. \[[@CR9]\] showed that IC1 strains have been prevalent in the past years. Therefore, it can be concluded that the clonal transition dynamics of strains in our hospital is in progress. The increased prevalence of IC2 in our hospital concomitant with elevated resistance to the first and second generations of tetracycline strengthens the fact that the IC 2 strains have higher resistance genetic determinants than IC1 strains. This consequence is in accordance with the previous study where IC 2 strains were relatively older than the other ICs which have been undergoing extensive diversification \[[@CR21]\].

Conclusions {#Sec12}
===========

With the best of our knowledge, this study is the first comparison of clinical strains of CRAB strains in the same location in two periods in Iran. Our data indicates that despite not using tetracyclines in treatment of Acinetobacter infections, the increased resistance to tetracyclines is likely duo to the clonal transition dynamics of strains with replacement of IC2 clones which contain higher prevalence of resistance determinants. Molecular detection of tetracycline resistance determinants in our hospital is due to the other efflux pumps rather than tetA and tetB efflux pumps. Eventually, to overcome the increasing resistance to antibiotics, some prerequisites should be considered e.g., improving antibiotic stewardship programs (ASPs), hygienic surveillance programs, epidemiological study of outbreak strains, and concrete infection control.
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